Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.95688663 |
2 | one-carbon compound transport (GO:0019755) | 4.89649148 |
3 | modulation by symbiont of host immune response (GO:0052553) | 4.61455757 |
4 | positive regulation by symbiont of host defense response (GO:0052509) | 4.61455757 |
5 | modulation by symbiont of host defense response (GO:0052031) | 4.61455757 |
6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.61455757 |
7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.61455757 |
8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.61455757 |
9 | microglial cell activation (GO:0001774) | 4.56113072 |
10 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.34707770 |
11 | neutrophil activation involved in immune response (GO:0002283) | 4.17771922 |
12 | positive regulation of respiratory burst (GO:0060267) | 4.15943054 |
13 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.07898085 |
14 | renal absorption (GO:0070293) | 4.01132572 |
15 | endothelium development (GO:0003158) | 3.95672553 |
16 | regulation of activation of Janus kinase activity (GO:0010533) | 3.90061468 |
17 | detection of molecule of bacterial origin (GO:0032490) | 3.88503532 |
18 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.88331661 |
19 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.86567674 |
20 | macrophage activation (GO:0042116) | 3.79024065 |
21 | positive regulation of macrophage activation (GO:0043032) | 3.72933494 |
22 | superoxide anion generation (GO:0042554) | 3.67317378 |
23 | adenine nucleotide transport (GO:0051503) | 3.66533712 |
24 | positive regulation of chemokine secretion (GO:0090197) | 3.66469980 |
25 | purine ribonucleotide transport (GO:0015868) | 3.66105745 |
26 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.63606239 |
27 | macrophage activation involved in immune response (GO:0002281) | 3.62211863 |
28 | response to peptidoglycan (GO:0032494) | 3.55056877 |
29 | regulation of respiratory burst (GO:0060263) | 3.54580564 |
30 | positive regulation of interferon-alpha production (GO:0032727) | 3.45507793 |
31 | cellular response to exogenous dsRNA (GO:0071360) | 3.43399836 |
32 | immunoglobulin mediated immune response (GO:0016064) | 3.40162341 |
33 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.38757235 |
34 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.36121191 |
35 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.34296598 |
36 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 3.30273747 |
37 | response to host immune response (GO:0052572) | 3.29645291 |
38 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.29645291 |
39 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.28417037 |
40 | phospholipid efflux (GO:0033700) | 3.25454311 |
41 | cellular response to type I interferon (GO:0071357) | 3.23546774 |
42 | type I interferon signaling pathway (GO:0060337) | 3.23546774 |
43 | regulation of cholesterol esterification (GO:0010872) | 3.23051728 |
44 | regulation of interferon-alpha production (GO:0032647) | 3.22552480 |
45 | response to type I interferon (GO:0034340) | 3.18248120 |
46 | chronic inflammatory response (GO:0002544) | 3.17804741 |
47 | lipoxygenase pathway (GO:0019372) | 3.17787383 |
48 | low-density lipoprotein particle remodeling (GO:0034374) | 3.16741360 |
49 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.15586123 |
50 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.12808666 |
51 | artery smooth muscle contraction (GO:0014824) | 3.12346187 |
52 | negative regulation of mast cell activation (GO:0033004) | 3.09863107 |
53 | negative regulation of growth of symbiont in host (GO:0044130) | 3.08417624 |
54 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.08417624 |
55 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.08417624 |
56 | regulation of growth of symbiont in host (GO:0044126) | 3.08417624 |
57 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.07520652 |
58 | positive regulation of mast cell degranulation (GO:0043306) | 3.07520652 |
59 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.06351287 |
60 | neutrophil activation (GO:0042119) | 3.06269236 |
61 | negative regulation of protein activation cascade (GO:2000258) | 3.05432593 |
62 | T-helper 1 type immune response (GO:0042088) | 3.04427690 |
63 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.02546934 |
64 | positive regulation of macrophage differentiation (GO:0045651) | 3.01883991 |
65 | response to interferon-beta (GO:0035456) | 3.00743038 |
66 | negative regulation of interleukin-12 production (GO:0032695) | 2.99410049 |
67 | positive regulation of antigen processing and presentation (GO:0002579) | 2.99317384 |
68 | purine nucleotide transport (GO:0015865) | 2.99168674 |
69 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.97704585 |
70 | Rap protein signal transduction (GO:0032486) | 2.97187968 |
71 | detection of external biotic stimulus (GO:0098581) | 2.92929306 |
72 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.92245325 |
73 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.91626153 |
74 | negative regulation of complement activation (GO:0045916) | 2.90150498 |
75 | negative regulation of lipid storage (GO:0010888) | 2.89491427 |
76 | high-density lipoprotein particle remodeling (GO:0034375) | 2.87636697 |
77 | ovulation from ovarian follicle (GO:0001542) | 2.87202211 |
78 | granulocyte activation (GO:0036230) | 2.86426208 |
79 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.85683465 |
80 | regulation of monocyte chemotaxis (GO:0090025) | 2.83771849 |
81 | peptide catabolic process (GO:0043171) | 2.82627681 |
82 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.82313028 |
83 | positive regulation of T cell migration (GO:2000406) | 2.81886882 |
84 | regulation of mast cell degranulation (GO:0043304) | 2.81689612 |
85 | detection of biotic stimulus (GO:0009595) | 2.81587461 |
86 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.81381130 |
87 | response to muramyl dipeptide (GO:0032495) | 2.80902048 |
88 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.80312620 |
89 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.80309286 |
90 | gap junction assembly (GO:0016264) | 2.79980375 |
91 | histamine secretion (GO:0001821) | 2.79262274 |
92 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.78462972 |
93 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.78082944 |
94 | detection of other organism (GO:0098543) | 2.78076630 |
95 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.77910399 |
96 | response to host (GO:0075136) | 2.77830991 |
97 | response to host defenses (GO:0052200) | 2.77830991 |
98 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.77830991 |
99 | positive regulation of lymphocyte migration (GO:2000403) | 2.73211705 |
100 | regulation of mast cell activation (GO:0033003) | 2.72951504 |
101 | response to protozoan (GO:0001562) | 2.71764787 |
102 | negative regulation of protein autophosphorylation (GO:0031953) | 2.70983440 |
103 | positive regulation of mast cell activation (GO:0033005) | 2.70906965 |
104 | tonic smooth muscle contraction (GO:0014820) | 2.70681099 |
105 | energy homeostasis (GO:0097009) | 2.70280156 |
106 | regulation of chemokine secretion (GO:0090196) | 2.70251774 |
107 | nucleotide transport (GO:0006862) | 2.70218865 |
108 | hyperosmotic salinity response (GO:0042538) | 2.69373002 |
109 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.69161163 |
110 | amino acid import (GO:0043090) | 2.69106202 |
111 | regulation of glomerular filtration (GO:0003093) | 2.69101719 |
112 | phospholipid homeostasis (GO:0055091) | 2.69019890 |
113 | positive regulation of T cell chemotaxis (GO:0010820) | 2.68659812 |
114 | regulation of T cell chemotaxis (GO:0010819) | 2.68659812 |
115 | reverse cholesterol transport (GO:0043691) | 2.67877884 |
116 | atrial cardiac muscle cell action potential (GO:0086014) | 2.67744643 |
117 | defense response to protozoan (GO:0042832) | 2.67488917 |
118 | negative regulation of humoral immune response (GO:0002921) | 2.67405370 |
119 | skeletal muscle tissue regeneration (GO:0043403) | 2.67112742 |
120 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.66081161 |
121 | keratinocyte development (GO:0003334) | 2.65465472 |
122 | kidney morphogenesis (GO:0060993) | 2.62751548 |
123 | B cell mediated immunity (GO:0019724) | 2.62114320 |
124 | positive regulation of leukocyte degranulation (GO:0043302) | 2.61877547 |
125 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.61652973 |
126 | cholesterol efflux (GO:0033344) | 2.60736675 |
127 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.60511014 |
128 | myeloid cell activation involved in immune response (GO:0002275) | 2.60041615 |
129 | regulation of RIG-I signaling pathway (GO:0039535) | 2.59451869 |
130 | amino sugar catabolic process (GO:0046348) | 2.59348482 |
131 | regulation of T-helper 1 type immune response (GO:0002825) | 2.58459950 |
132 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.58373842 |
133 | pinocytosis (GO:0006907) | 2.57969098 |
134 | opsonization (GO:0008228) | 2.57498505 |
135 | phagocytosis, engulfment (GO:0006911) | 2.55940213 |
136 | positive regulation of interferon-beta production (GO:0032728) | 2.55547916 |
137 | transcytosis (GO:0045056) | 2.55504389 |
138 | plasma lipoprotein particle assembly (GO:0034377) | 2.54655338 |
139 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.53781483 |
140 | phagocytosis, recognition (GO:0006910) | 2.52251832 |
141 | regulation of antigen processing and presentation (GO:0002577) | 2.52187385 |
142 | gas transport (GO:0015669) | 2.51396218 |
143 | Notch signaling involved in heart development (GO:0061314) | 2.51372991 |
144 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.51371584 |
145 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.51231187 |
146 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.50601597 |
147 | negative regulation of tissue remodeling (GO:0034104) | 2.50559982 |
148 | regulation of mononuclear cell migration (GO:0071675) | 2.48233051 |
149 | cytokine secretion (GO:0050663) | 2.47855808 |
150 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.47801127 |
151 | myeloid leukocyte activation (GO:0002274) | 2.47728356 |
152 | positive regulation of chemokine production (GO:0032722) | 2.47436960 |
153 | adhesion of symbiont to host (GO:0044406) | 2.47257176 |
154 | uronic acid metabolic process (GO:0006063) | 2.47047491 |
155 | glucuronate metabolic process (GO:0019585) | 2.47047491 |
156 | positive regulation of interleukin-12 production (GO:0032735) | 2.45934690 |
157 | I-kappaB phosphorylation (GO:0007252) | 2.45876334 |
158 | response to interferon-gamma (GO:0034341) | 2.43776013 |
159 | cellular response to interferon-gamma (GO:0071346) | 2.40524048 |
160 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.40477850 |
161 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.40477850 |
162 | oligosaccharide catabolic process (GO:0009313) | 2.40459603 |
163 | regulation of vitamin metabolic process (GO:0030656) | 2.39714026 |
164 | regulation of tolerance induction (GO:0002643) | 2.38781677 |
165 | regulation of macrophage activation (GO:0043030) | 2.36454588 |
166 | ER overload response (GO:0006983) | 2.36197520 |
167 | plasma lipoprotein particle clearance (GO:0034381) | 2.35490204 |
168 | positive regulation of tolerance induction (GO:0002645) | 2.33966616 |
169 | regulation of germinal center formation (GO:0002634) | 2.33866890 |
170 | positive regulation of interleukin-8 production (GO:0032757) | 2.33508869 |
171 | positive regulation of interleukin-6 production (GO:0032755) | 2.32802163 |
172 | response to interferon-alpha (GO:0035455) | 2.32195286 |
173 | negative regulation of viral genome replication (GO:0045071) | 2.31978840 |
174 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.31569944 |
175 | regulation of interleukin-1 secretion (GO:0050704) | 2.31519393 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.42183773 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.72407288 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.34790953 |
4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.09039169 |
5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.19312364 |
6 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.17590016 |
7 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.71048218 |
8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.70482972 |
9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.67268924 |
10 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.62564624 |
11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.59520634 |
12 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.57921048 |
13 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.56922703 |
14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.56798285 |
15 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.38414823 |
16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.28730575 |
17 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.20778378 |
18 | GATA1_22025678_ChIP-Seq_K562_Human | 2.19932301 |
19 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.17797991 |
20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.12944656 |
21 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.11803271 |
22 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.10140068 |
23 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.05440616 |
24 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.85446099 |
25 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.78831722 |
26 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.70320994 |
27 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.69011737 |
28 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.69011737 |
29 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.68716733 |
30 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.65301201 |
31 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.61704083 |
32 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.61107635 |
33 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.59341734 |
34 | CJUN_26792858_Chip-Seq_BT549_Human | 1.53665776 |
35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.48233202 |
36 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.46719786 |
37 | RXR_22108803_ChIP-Seq_LS180_Human | 1.46669264 |
38 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.45861323 |
39 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.44771861 |
40 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.43914682 |
41 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.42783357 |
42 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.42224095 |
43 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.42129839 |
44 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.42128868 |
45 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.40453203 |
46 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.40161379 |
47 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.37358124 |
48 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.36003667 |
49 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.34399464 |
50 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.33457149 |
51 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.28765265 |
52 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.27706215 |
53 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.26374056 |
54 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.25207471 |
55 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.25207471 |
56 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.21958974 |
57 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.21953232 |
58 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.21357475 |
59 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20797894 |
60 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.19819533 |
61 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.19609245 |
62 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.19433083 |
63 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.19058409 |
64 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.15635883 |
65 | * MYB_26560356_Chip-Seq_TH2_Human | 1.14732880 |
66 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.13436169 |
67 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.12548632 |
68 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.12007264 |
69 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.11617798 |
70 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.11494463 |
71 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.11427923 |
72 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.09433032 |
73 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.09421062 |
74 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.08766634 |
75 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08739963 |
76 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.08560486 |
77 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.08413572 |
78 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.08284833 |
79 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.07375128 |
80 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.06853900 |
81 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.06492035 |
82 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.05717332 |
83 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.05680369 |
84 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.05002421 |
85 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.04697617 |
86 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.04223991 |
87 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.03034950 |
88 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.03030385 |
89 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.02812288 |
90 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.00447939 |
91 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00057152 |
92 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.99707714 |
93 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.99371941 |
94 | MYB_26560356_Chip-Seq_TH1_Human | 0.99354190 |
95 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.98544274 |
96 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98523185 |
97 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.98134844 |
98 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97372000 |
99 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97314516 |
100 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.97149211 |
101 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.97149211 |
102 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.97149211 |
103 | SPI1_23127762_ChIP-Seq_K562_Human | 0.97060652 |
104 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.96955698 |
105 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.96546118 |
106 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.96308488 |
107 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.96029962 |
108 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.95478082 |
109 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.95270727 |
110 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.95175785 |
111 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.94357178 |
112 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.94234508 |
113 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94092332 |
114 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93851011 |
115 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.93150439 |
116 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92595491 |
117 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.92542128 |
118 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.92396955 |
119 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.91358109 |
120 | TP53_16413492_ChIP-PET_HCT116_Human | 0.91251229 |
121 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.90957430 |
122 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.90236895 |
123 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.90043752 |
124 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89983880 |
125 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.89973539 |
126 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.89864127 |
127 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.89370853 |
128 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.89026827 |
129 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.88595431 |
130 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.88339725 |
131 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.88066052 |
132 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.87555643 |
133 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.87251309 |
134 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.87194833 |
135 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.86869109 |
136 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.86590510 |
137 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86450920 |
138 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85081691 |
139 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.83496301 |
140 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.83340744 |
141 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.83226869 |
142 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.81709255 |
143 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.81709255 |
144 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.81229661 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003136_yellow_coat_color | 4.24339086 |
2 | MP0001835_abnormal_antigen_presentation | 3.37148371 |
3 | MP0003690_abnormal_glial_cell | 3.25915963 |
4 | MP0003303_peritoneal_inflammation | 3.25064893 |
5 | MP0003724_increased_susceptibility_to | 3.09852734 |
6 | MP0002148_abnormal_hypersensitivity_rea | 2.97823574 |
7 | MP0005171_absent_coat_pigmentation | 2.92716846 |
8 | MP0001853_heart_inflammation | 2.70759673 |
9 | MP0000372_irregular_coat_pigmentation | 2.62543634 |
10 | MP0002419_abnormal_innate_immunity | 2.57609227 |
11 | MP0009764_decreased_sensitivity_to | 2.49203871 |
12 | MP0003279_aneurysm | 2.44037257 |
13 | MP0009785_altered_susceptibility_to | 2.38979417 |
14 | MP0005409_darkened_coat_color | 2.31190124 |
15 | MP0003075_altered_response_to | 2.30976712 |
16 | MP0000569_abnormal_digit_pigmentation | 2.17649126 |
17 | MP0005377_hearing/vestibular/ear_phenot | 2.16959396 |
18 | MP0003878_abnormal_ear_physiology | 2.16959396 |
19 | MP0002132_abnormal_respiratory_system | 2.12365962 |
20 | MP0005365_abnormal_bile_salt | 2.02651317 |
21 | MP0005000_abnormal_immune_tolerance | 2.00849921 |
22 | MP0003300_gastrointestinal_ulcer | 1.99835268 |
23 | MP0003436_decreased_susceptibility_to | 1.96417434 |
24 | MP0001542_abnormal_bone_strength | 1.94205686 |
25 | MP0002139_abnormal_hepatobiliary_system | 1.84354278 |
26 | MP0005058_abnormal_lysosome_morphology | 1.83154321 |
27 | MP0005025_abnormal_response_to | 1.82044212 |
28 | MP0005174_abnormal_tail_pigmentation | 1.81164473 |
29 | MP0001790_abnormal_immune_system | 1.80648131 |
30 | MP0005387_immune_system_phenotype | 1.80648131 |
31 | MP0002452_abnormal_antigen_presenting | 1.79693335 |
32 | MP0003195_calcinosis | 1.79605587 |
33 | MP0003828_pulmonary_edema | 1.77458683 |
34 | MP0008004_abnormal_stomach_pH | 1.76055477 |
35 | MP0002254_reproductive_system_inflammat | 1.74296212 |
36 | MP0003186_abnormal_redox_activity | 1.70294713 |
37 | MP0005671_abnormal_response_to | 1.70113132 |
38 | MP0003950_abnormal_plasma_membrane | 1.68685963 |
39 | MP0006082_CNS_inflammation | 1.67657582 |
40 | MP0003806_abnormal_nucleotide_metabolis | 1.62214356 |
41 | MP0010368_abnormal_lymphatic_system | 1.60575221 |
42 | MP0005166_decreased_susceptibility_to | 1.58017055 |
43 | MP0004782_abnormal_surfactant_physiolog | 1.57815997 |
44 | MP0005167_abnormal_blood-brain_barrier | 1.57357571 |
45 | MP0000015_abnormal_ear_pigmentation | 1.56799444 |
46 | MP0002723_abnormal_immune_serum | 1.54381507 |
47 | MP0002166_altered_tumor_susceptibility | 1.50238312 |
48 | MP0001819_abnormal_immune_cell | 1.50037993 |
49 | MP0002420_abnormal_adaptive_immunity | 1.48585318 |
50 | MP0000343_altered_response_to | 1.47363663 |
51 | MP0005451_abnormal_body_composition | 1.46584447 |
52 | MP0001800_abnormal_humoral_immune | 1.46405682 |
53 | MP0006054_spinal_hemorrhage | 1.45685022 |
54 | MP0009697_abnormal_copulation | 1.45519696 |
55 | MP0004883_abnormal_blood_vessel | 1.42731722 |
56 | MP0008260_abnormal_autophagy | 1.40256478 |
57 | MP0005464_abnormal_platelet_physiology | 1.38701801 |
58 | MP0001879_abnormal_lymphatic_vessel | 1.37831166 |
59 | MP0002998_abnormal_bone_remodeling | 1.35458818 |
60 | MP0000371_diluted_coat_color | 1.35251479 |
61 | MP0009384_cardiac_valve_regurgitation | 1.31474799 |
62 | MP0003191_abnormal_cellular_cholesterol | 1.31063999 |
63 | MP0002138_abnormal_hepatobiliary_system | 1.30939352 |
64 | MP0002277_abnormal_respiratory_mucosa | 1.30667436 |
65 | MP0003172_abnormal_lysosome_physiology | 1.29904865 |
66 | MP0005164_abnormal_response_to | 1.28745900 |
67 | MP0002405_respiratory_system_inflammati | 1.28248869 |
68 | MP0010155_abnormal_intestine_physiology | 1.23177633 |
69 | MP0003448_altered_tumor_morphology | 1.22870710 |
70 | MP0001533_abnormal_skeleton_physiology | 1.22020906 |
71 | MP0001845_abnormal_inflammatory_respons | 1.21990257 |
72 | MP0001986_abnormal_taste_sensitivity | 1.21103623 |
73 | MP0000566_synostosis | 1.20371389 |
74 | MP0008438_abnormal_cutaneous_collagen | 1.19386212 |
75 | MP0000685_abnormal_immune_system | 1.18186458 |
76 | MP0008007_abnormal_cellular_replicative | 1.16409675 |
77 | MP0000465_gastrointestinal_hemorrhage | 1.16147759 |
78 | MP0009840_abnormal_foam_cell | 1.15863121 |
79 | MP0008469_abnormal_protein_level | 1.12947543 |
80 | MP0004264_abnormal_extraembryonic_tissu | 1.10419269 |
81 | MP0000767_abnormal_smooth_muscle | 1.08585947 |
82 | MP0004947_skin_inflammation | 1.08584058 |
83 | MP0005084_abnormal_gallbladder_morpholo | 1.04476834 |
84 | MP0008875_abnormal_xenobiotic_pharmacok | 1.04156334 |
85 | MP0003656_abnormal_erythrocyte_physiolo | 1.04081282 |
86 | MP0005646_abnormal_pituitary_gland | 1.02926772 |
87 | MP0009278_abnormal_bone_marrow | 1.01862061 |
88 | MP0000604_amyloidosis | 1.00723778 |
89 | MP0002009_preneoplasia | 0.99638222 |
90 | MP0004381_abnormal_hair_follicle | 0.99205940 |
91 | MP0002396_abnormal_hematopoietic_system | 0.94545501 |
92 | MP0001958_emphysema | 0.94184527 |
93 | MP0005390_skeleton_phenotype | 0.91891563 |
94 | MP0005410_abnormal_fertilization | 0.90672861 |
95 | MP0005165_increased_susceptibility_to | 0.90665455 |
96 | MP0009333_abnormal_splenocyte_physiolog | 0.88396644 |
97 | MP0003718_maternal_effect | 0.85584057 |
98 | MP0003941_abnormal_skin_development | 0.85474005 |
99 | MP0000716_abnormal_immune_system | 0.85092311 |
100 | MP0009643_abnormal_urine_homeostasis | 0.84488389 |
101 | MP0001915_intracranial_hemorrhage | 0.84297901 |
102 | MP0001881_abnormal_mammary_gland | 0.84027527 |
103 | MP0000249_abnormal_blood_vessel | 0.83625360 |
104 | MP0001851_eye_inflammation | 0.82570111 |
105 | MP0002295_abnormal_pulmonary_circulatio | 0.81947511 |
106 | MP0001666_abnormal_nutrient_absorption | 0.81733385 |
107 | MP0004510_myositis | 0.80458736 |
108 | MP0010329_abnormal_lipoprotein_level | 0.80458679 |
109 | MP0003183_abnormal_peptide_metabolism | 0.79002622 |
110 | MP0002136_abnormal_kidney_physiology | 0.78648599 |
111 | MP0005085_abnormal_gallbladder_physiolo | 0.78442878 |
112 | MP0005023_abnormal_wound_healing | 0.78263088 |
113 | MP0005408_hypopigmentation | 0.77993038 |
114 | MP0002089_abnormal_postnatal_growth/wei | 0.77212931 |
115 | MP0005310_abnormal_salivary_gland | 0.76640984 |
116 | MP0003943_abnormal_hepatobiliary_system | 0.76244225 |
117 | MP0002098_abnormal_vibrissa_morphology | 0.75472518 |
118 | * MP0000609_abnormal_liver_physiology | 0.73976285 |
119 | MP0003866_abnormal_defecation | 0.72536223 |
120 | MP0002398_abnormal_bone_marrow | 0.71833746 |
121 | MP0000689_abnormal_spleen_morphology | 0.71181299 |
122 | MP0009763_increased_sensitivity_to | 0.70348524 |
123 | MP0002006_tumorigenesis | 0.70316772 |
124 | MP0001545_abnormal_hematopoietic_system | 0.69398124 |
125 | MP0005397_hematopoietic_system_phenotyp | 0.69398124 |
126 | MP0002877_abnormal_melanocyte_morpholog | 0.68213225 |
127 | MP0004019_abnormal_vitamin_homeostasis | 0.67310239 |
128 | MP0000627_abnormal_mammary_gland | 0.65929367 |
129 | MP0002876_abnormal_thyroid_physiology | 0.65829247 |
130 | MP0003045_fibrosis | 0.65723538 |
131 | MP0000858_altered_metastatic_potential | 0.65473184 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 4.53887035 |
2 | Aplasia involving bones of the extremities (HP:0009825) | 4.37084343 |
3 | Aplasia involving bones of the upper limbs (HP:0009823) | 4.37084343 |
4 | Aplasia of the phalanges of the hand (HP:0009802) | 4.37084343 |
5 | Eczematoid dermatitis (HP:0000976) | 4.28957594 |
6 | Recurrent bacterial skin infections (HP:0005406) | 4.27315037 |
7 | Amyloidosis (HP:0011034) | 4.02320691 |
8 | Short middle phalanx of the 5th finger (HP:0004220) | 3.79510240 |
9 | Abnormality of the axillary hair (HP:0100134) | 3.79162193 |
10 | Abnormality of secondary sexual hair (HP:0009888) | 3.79162193 |
11 | Dry hair (HP:0011359) | 3.78889091 |
12 | Tetraparesis (HP:0002273) | 3.66918368 |
13 | White forelock (HP:0002211) | 3.54120300 |
14 | Albinism (HP:0001022) | 3.47241551 |
15 | Patchy hypopigmentation of hair (HP:0011365) | 3.46885328 |
16 | Systemic lupus erythematosus (HP:0002725) | 3.46811472 |
17 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.43360733 |
18 | Prostate neoplasm (HP:0100787) | 3.36000331 |
19 | Retrobulbar optic neuritis (HP:0100654) | 3.24749892 |
20 | Optic neuritis (HP:0100653) | 3.24749892 |
21 | Abnormality of macrophages (HP:0004311) | 3.16603185 |
22 | Gingival bleeding (HP:0000225) | 3.15616204 |
23 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.15197009 |
24 | Petechiae (HP:0000967) | 3.13780383 |
25 | Basal ganglia calcification (HP:0002135) | 3.08894038 |
26 | Orchitis (HP:0100796) | 3.08109031 |
27 | Hypoplastic left heart (HP:0004383) | 3.06239220 |
28 | Thick nail (HP:0001805) | 3.05452077 |
29 | Autoimmune hemolytic anemia (HP:0001890) | 3.03723979 |
30 | Congenital sensorineural hearing impairment (HP:0008527) | 3.02859181 |
31 | Spontaneous abortion (HP:0005268) | 3.00311027 |
32 | Mediastinal lymphadenopathy (HP:0100721) | 2.99622387 |
33 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 2.98364061 |
34 | Myositis (HP:0100614) | 2.83293372 |
35 | Vacuolated lymphocytes (HP:0001922) | 2.78601141 |
36 | Joint swelling (HP:0001386) | 2.76686337 |
37 | Abnormality of the columella (HP:0009929) | 2.75541834 |
38 | Pustule (HP:0200039) | 2.72230233 |
39 | Increased CSF protein (HP:0002922) | 2.71728505 |
40 | Long nose (HP:0003189) | 2.71677674 |
41 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.71578581 |
42 | Hypoplasia of the fovea (HP:0007750) | 2.71578581 |
43 | Glomerulonephritis (HP:0000099) | 2.70596901 |
44 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 2.68816597 |
45 | Loss of speech (HP:0002371) | 2.65526156 |
46 | Axonal loss (HP:0003447) | 2.63738354 |
47 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.59294206 |
48 | Premature loss of primary teeth (HP:0006323) | 2.58742068 |
49 | Prolonged neonatal jaundice (HP:0006579) | 2.55965407 |
50 | Gingivitis (HP:0000230) | 2.54680658 |
51 | Gastrointestinal infarctions (HP:0005244) | 2.53859730 |
52 | Hypoplastic heart (HP:0001961) | 2.52249058 |
53 | Malnutrition (HP:0004395) | 2.52005825 |
54 | Hemoptysis (HP:0002105) | 2.51721357 |
55 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.51551398 |
56 | Recurrent skin infections (HP:0001581) | 2.49811495 |
57 | Complement deficiency (HP:0004431) | 2.43704891 |
58 | Steatorrhea (HP:0002570) | 2.43228543 |
59 | Recurrent pneumonia (HP:0006532) | 2.39066840 |
60 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 2.36758512 |
61 | Abnormality of molar (HP:0011077) | 2.35788579 |
62 | Abnormality of molar morphology (HP:0011070) | 2.35788579 |
63 | Autoimmune thrombocytopenia (HP:0001973) | 2.34318667 |
64 | Gangrene (HP:0100758) | 2.32576043 |
65 | Abnormality of permanent molar morphology (HP:0011071) | 2.32094466 |
66 | Abnormality of the dental root (HP:0006486) | 2.32094466 |
67 | Taurodontia (HP:0000679) | 2.32094466 |
68 | Stomach cancer (HP:0012126) | 2.31733357 |
69 | Abnormality of glycolipid metabolism (HP:0010969) | 2.29628630 |
70 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.29628630 |
71 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.29628630 |
72 | Polyneuropathy (HP:0001271) | 2.28869859 |
73 | Abnormality of the fovea (HP:0000493) | 2.27664697 |
74 | Short hallux (HP:0010109) | 2.26190495 |
75 | Fat malabsorption (HP:0002630) | 2.25725697 |
76 | Onycholysis (HP:0001806) | 2.25092972 |
77 | Abnormality of the common coagulation pathway (HP:0010990) | 2.24505408 |
78 | Increased serum ferritin (HP:0003281) | 2.21900293 |
79 | Dysostosis multiplex (HP:0000943) | 2.21012482 |
80 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.18453223 |
81 | Generalized hypopigmentation (HP:0007513) | 2.18184237 |
82 | Epistaxis (HP:0000421) | 2.17656264 |
83 | Abnormality of iron homeostasis (HP:0011031) | 2.16874318 |
84 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.16207415 |
85 | Nephritis (HP:0000123) | 2.15752460 |
86 | Short nail (HP:0001799) | 2.14114336 |
87 | Abnormality of the dental pulp (HP:0006479) | 2.11272774 |
88 | Osteolytic defects of the hand bones (HP:0009699) | 2.09277469 |
89 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.09277469 |
90 | Hypobetalipoproteinemia (HP:0003563) | 2.09137814 |
91 | Increased IgM level (HP:0003496) | 2.08545921 |
92 | Purpura (HP:0000979) | 2.07444487 |
93 | Chronic obstructive pulmonary disease (HP:0006510) | 2.06664870 |
94 | Obstructive lung disease (HP:0006536) | 2.06664870 |
95 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.05539086 |
96 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.05539086 |
97 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.05539086 |
98 | Mixed hearing impairment (HP:0000410) | 2.05138689 |
99 | Myocardial infarction (HP:0001658) | 2.04297569 |
100 | Stomatitis (HP:0010280) | 2.03730275 |
101 | Vasculitis (HP:0002633) | 2.02076644 |
102 | Tongue fasciculations (HP:0001308) | 2.01561484 |
103 | Recurrent fungal infections (HP:0002841) | 2.01245475 |
104 | Congenital, generalized hypertrichosis (HP:0004540) | 2.00592880 |
105 | Intrahepatic cholestasis (HP:0001406) | 2.00523456 |
106 | Keratoconjunctivitis sicca (HP:0001097) | 2.00491849 |
107 | Thrombophlebitis (HP:0004418) | 1.99462736 |
108 | Anorexia (HP:0002039) | 1.99447380 |
109 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.99109736 |
110 | Paraparesis (HP:0002385) | 1.98881228 |
111 | Diaphragmatic weakness (HP:0009113) | 1.98744686 |
112 | Selective tooth agenesis (HP:0001592) | 1.98597368 |
113 | Disinhibition (HP:0000734) | 1.98434631 |
114 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.98399662 |
115 | Craniofacial hyperostosis (HP:0004493) | 1.98170045 |
116 | Abnormality of complement system (HP:0005339) | 1.97899184 |
117 | Pulmonary embolism (HP:0002204) | 1.97822544 |
118 | Muscle fibrillation (HP:0010546) | 1.97016329 |
119 | Renal tubular acidosis (HP:0001947) | 1.95773739 |
120 | Prolonged bleeding time (HP:0003010) | 1.95309258 |
121 | Chronic diarrhea (HP:0002028) | 1.95107724 |
122 | Pulmonary infiltrates (HP:0002113) | 1.93155456 |
123 | Recurrent lower respiratory tract infections (HP:0002783) | 1.92620956 |
124 | Mucopolysacchariduria (HP:0008155) | 1.90205409 |
125 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.90205409 |
126 | Eosinophilia (HP:0001880) | 1.88785391 |
127 | Hepatosplenomegaly (HP:0001433) | 1.87922721 |
128 | Keratoconjunctivitis (HP:0001096) | 1.87792628 |
129 | Poor head control (HP:0002421) | 1.87478273 |
130 | Concave nail (HP:0001598) | 1.87440338 |
131 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.87096950 |
132 | Increased cerebral lipofuscin (HP:0011813) | 1.85772360 |
133 | Symptomatic seizures (HP:0011145) | 1.85647461 |
134 | Episodic fever (HP:0001954) | 1.85321109 |
135 | Alveolar cell carcinoma (HP:0006519) | 1.85294538 |
136 | Arterial thrombosis (HP:0004420) | 1.84141210 |
137 | Pulmonary artery stenosis (HP:0004415) | 1.82596547 |
138 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.82357748 |
139 | Abnormality of the prostate (HP:0008775) | 1.82060447 |
140 | Periodontitis (HP:0000704) | 1.82049856 |
141 | Glomerulopathy (HP:0100820) | 1.81258468 |
142 | Hypolipoproteinemia (HP:0010981) | 1.80524555 |
143 | Parakeratosis (HP:0001036) | 1.79801130 |
144 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.79328901 |
145 | Generalized hypopigmentation of hair (HP:0011358) | 1.78361403 |
146 | Recurrent sinusitis (HP:0011108) | 1.78190477 |
147 | Vascular calcification (HP:0004934) | 1.77681419 |
148 | Hypoglycemic seizures (HP:0002173) | 1.77634597 |
149 | Recurrent cutaneous fungal infections (HP:0011370) | 1.76752096 |
150 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.76752096 |
151 | Median cleft lip (HP:0000161) | 1.73919956 |
152 | Cranial hyperostosis (HP:0004437) | 1.73449549 |
153 | Nausea (HP:0002018) | 1.73173040 |
154 | Abnormality of primary teeth (HP:0006481) | 1.73076584 |
155 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.73048321 |
156 | Cheilitis (HP:0100825) | 1.73039386 |
157 | Meningitis (HP:0001287) | 1.72947500 |
158 | Abnormality of the renal collecting system (HP:0004742) | 1.72767688 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MKNK2 | 6.69158001 |
2 | TNIK | 5.75418092 |
3 | MKNK1 | 4.04376517 |
4 | IRAK3 | 4.04237042 |
5 | MAP3K14 | 3.36480312 |
6 | IRAK4 | 2.50452084 |
7 | NEK6 | 2.25560452 |
8 | FER | 2.17753891 |
9 | BRSK2 | 2.13114363 |
10 | SIK3 | 2.11810627 |
11 | TGFBR2 | 2.11810546 |
12 | LMTK2 | 1.91035884 |
13 | IKBKB | 1.82831786 |
14 | PDK2 | 1.80638415 |
15 | MUSK | 1.78848732 |
16 | TXK | 1.75461958 |
17 | STK16 | 1.74794022 |
18 | GRK7 | 1.74555353 |
19 | TAOK3 | 1.67554720 |
20 | MST4 | 1.67455946 |
21 | MAPK7 | 1.64187454 |
22 | TIE1 | 1.58706282 |
23 | ZAK | 1.52040220 |
24 | PIM2 | 1.47221238 |
25 | ACVR1B | 1.39705595 |
26 | FRK | 1.39645079 |
27 | TYK2 | 1.39394838 |
28 | IKBKE | 1.32529040 |
29 | EPHA2 | 1.31960805 |
30 | MAPK12 | 1.29422841 |
31 | TEC | 1.25017247 |
32 | TRIM28 | 1.24545537 |
33 | PBK | 1.22372050 |
34 | TBK1 | 1.21296066 |
35 | STK10 | 1.20175091 |
36 | MAP3K2 | 1.19198803 |
37 | STK38L | 1.18565863 |
38 | NLK | 1.17463141 |
39 | PIK3CA | 1.16677631 |
40 | STK24 | 1.15520090 |
41 | DDR2 | 1.15052430 |
42 | MAP3K3 | 1.13173297 |
43 | EIF2AK2 | 1.12359652 |
44 | OXSR1 | 1.12263687 |
45 | NEK9 | 1.12102465 |
46 | MATK | 1.11714988 |
47 | BMPR2 | 1.11417182 |
48 | CHUK | 1.10951457 |
49 | TRPM7 | 1.06094596 |
50 | RIPK4 | 1.03581206 |
51 | WEE1 | 0.99184911 |
52 | STK39 | 0.98576967 |
53 | ADRBK2 | 0.93422733 |
54 | NUAK1 | 0.93258525 |
55 | ABL2 | 0.92405035 |
56 | ERBB3 | 0.92100183 |
57 | BMPR1B | 0.91597574 |
58 | RIPK1 | 0.90053613 |
59 | MAP4K1 | 0.89959459 |
60 | MAP3K13 | 0.88809018 |
61 | PAK3 | 0.87106122 |
62 | PINK1 | 0.85879794 |
63 | EIF2AK3 | 0.84503087 |
64 | BLK | 0.84442821 |
65 | NME2 | 0.83279041 |
66 | JAK3 | 0.82566006 |
67 | EPHA3 | 0.80282383 |
68 | JAK2 | 0.79371255 |
69 | PIK3CG | 0.78892676 |
70 | LYN | 0.78843477 |
71 | JAK1 | 0.74011055 |
72 | FES | 0.72894262 |
73 | PIM1 | 0.72810037 |
74 | FGR | 0.72337339 |
75 | PRKCI | 0.68838020 |
76 | CSF1R | 0.66897871 |
77 | AKT3 | 0.64844906 |
78 | PRKCE | 0.63459950 |
79 | GRK1 | 0.63401667 |
80 | CLK1 | 0.63148155 |
81 | KIT | 0.62976373 |
82 | CDK3 | 0.59723772 |
83 | INSRR | 0.59116250 |
84 | MAP4K2 | 0.56803563 |
85 | IGF1R | 0.54979662 |
86 | TNK2 | 0.54961741 |
87 | PRKCQ | 0.54347355 |
88 | MAPK15 | 0.53258638 |
89 | MAP3K12 | 0.51867147 |
90 | STK3 | 0.51639133 |
91 | SGK2 | 0.49871593 |
92 | MAPKAPK5 | 0.49678992 |
93 | PRKG2 | 0.48661505 |
94 | PTK2B | 0.46950651 |
95 | LRRK2 | 0.46147938 |
96 | BTK | 0.45836601 |
97 | MAPKAPK3 | 0.45729289 |
98 | ITK | 0.45424747 |
99 | BCR | 0.44673135 |
100 | HCK | 0.43801573 |
101 | IRAK2 | 0.42884890 |
102 | MAP2K2 | 0.42577616 |
103 | CDK6 | 0.42046167 |
104 | SGK3 | 0.41751788 |
105 | MOS | 0.41562189 |
106 | ABL1 | 0.41398886 |
107 | SYK | 0.40835946 |
108 | PRKCD | 0.40608253 |
109 | EGFR | 0.40553401 |
110 | MAP2K7 | 0.39776861 |
111 | PRKCG | 0.39223264 |
112 | MAP3K5 | 0.39144554 |
113 | ZAP70 | 0.38696011 |
114 | YES1 | 0.37673085 |
115 | CDC42BPA | 0.37389450 |
116 | CASK | 0.36838364 |
117 | PDK1 | 0.36423232 |
118 | MST1R | 0.34561577 |
119 | BRSK1 | 0.34066567 |
120 | ROCK1 | 0.34050994 |
121 | GSK3A | 0.33346053 |
122 | MAP3K11 | 0.32306262 |
123 | IRAK1 | 0.31947185 |
124 | PDPK1 | 0.31772104 |
125 | CSK | 0.31650694 |
126 | MAPK4 | 0.31225078 |
127 | MAP2K3 | 0.31167285 |
128 | MAPKAPK2 | 0.29625809 |
129 | PRPF4B | 0.27817191 |
130 | MARK3 | 0.27194260 |
131 | LCK | 0.26661041 |
132 | TAOK2 | 0.25343970 |
133 | PLK2 | 0.24841685 |
134 | ERN1 | 0.23292520 |
135 | STK4 | 0.23234555 |
136 | EPHB1 | 0.22389924 |
137 | MAP3K1 | 0.22104316 |
138 | PRKCA | 0.21438453 |
139 | FGFR3 | 0.20308301 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.70238975 |
2 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.68108241 |
3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.32873736 |
4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.24633221 |
5 | Malaria_Homo sapiens_hsa05144 | 2.20661862 |
6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.08079191 |
7 | Lysosome_Homo sapiens_hsa04142 | 2.06695048 |
8 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.05750365 |
9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.04876152 |
10 | Allograft rejection_Homo sapiens_hsa05330 | 2.04416944 |
11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.99545001 |
12 | Leishmaniasis_Homo sapiens_hsa05140 | 1.99425030 |
13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.99397908 |
14 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.96760570 |
15 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.94416764 |
16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.91766585 |
17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.86454809 |
18 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.86453911 |
19 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.83087299 |
20 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.80685742 |
21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.75343418 |
22 | Legionellosis_Homo sapiens_hsa05134 | 1.70230541 |
23 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.67149252 |
24 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.66175076 |
25 | Other glycan degradation_Homo sapiens_hsa00511 | 1.66016467 |
26 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.65130471 |
27 | Measles_Homo sapiens_hsa05162 | 1.52192174 |
28 | Tuberculosis_Homo sapiens_hsa05152 | 1.47534002 |
29 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.47446646 |
30 | Pertussis_Homo sapiens_hsa05133 | 1.45575833 |
31 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.45024695 |
32 | Phagosome_Homo sapiens_hsa04145 | 1.43176823 |
33 | Influenza A_Homo sapiens_hsa05164 | 1.41206136 |
34 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.38199060 |
35 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.37978819 |
36 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.36183092 |
37 | Mineral absorption_Homo sapiens_hsa04978 | 1.33294606 |
38 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.33278271 |
39 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.30144480 |
40 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.20146019 |
41 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.20119644 |
42 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.17376930 |
43 | Apoptosis_Homo sapiens_hsa04210 | 1.14765605 |
44 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.11743112 |
45 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.10704497 |
46 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.09628900 |
47 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.08140066 |
48 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.07998751 |
49 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.07199661 |
50 | Circadian rhythm_Homo sapiens_hsa04710 | 1.05264597 |
51 | Asthma_Homo sapiens_hsa05310 | 1.05147676 |
52 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.03017332 |
53 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.99529794 |
54 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.99246404 |
55 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.98038203 |
56 | Proteasome_Homo sapiens_hsa03050 | 0.96884470 |
57 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.96407036 |
58 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.96144475 |
59 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.96137331 |
60 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.94290102 |
61 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.93671974 |
62 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.90265200 |
63 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.88413835 |
64 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.87503789 |
65 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.85375075 |
66 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.85201088 |
67 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.85189615 |
68 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.83797634 |
69 | Salmonella infection_Homo sapiens_hsa05132 | 0.83509206 |
70 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.81550053 |
71 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.79584418 |
72 | Hepatitis C_Homo sapiens_hsa05160 | 0.79056970 |
73 | Retinol metabolism_Homo sapiens_hsa00830 | 0.76885107 |
74 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.73481689 |
75 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.71672732 |
76 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.71539745 |
77 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.71173300 |
78 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.69256302 |
79 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.68751879 |
80 | Peroxisome_Homo sapiens_hsa04146 | 0.64707634 |
81 | Shigellosis_Homo sapiens_hsa05131 | 0.63537447 |
82 | Histidine metabolism_Homo sapiens_hsa00340 | 0.63388295 |
83 | Hepatitis B_Homo sapiens_hsa05161 | 0.62740633 |
84 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.62665899 |
85 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.61909317 |
86 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.58917379 |
87 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.58841617 |
88 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.58443412 |
89 | Viral myocarditis_Homo sapiens_hsa05416 | 0.57467640 |
90 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.57419840 |
91 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.56098680 |
92 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.55974121 |
93 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.54394252 |
94 | Prion diseases_Homo sapiens_hsa05020 | 0.54387062 |
95 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.54180189 |
96 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.54171891 |
97 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.53529078 |
98 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.50850773 |
99 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.49592782 |
100 | Galactose metabolism_Homo sapiens_hsa00052 | 0.47195055 |
101 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.47191692 |
102 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.46311064 |
103 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.45997593 |
104 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.45026702 |
105 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.44629568 |
106 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.43978013 |
107 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43255559 |
108 | Amoebiasis_Homo sapiens_hsa05146 | 0.41220255 |
109 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.41101019 |
110 | Insulin resistance_Homo sapiens_hsa04931 | 0.40871519 |
111 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.40156614 |
112 | ABC transporters_Homo sapiens_hsa02010 | 0.39257603 |
113 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.38968640 |
114 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.38774571 |
115 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.37377257 |
116 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.37145241 |
117 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.36175790 |
118 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.35096789 |
119 | Protein export_Homo sapiens_hsa03060 | 0.34797057 |
120 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.34653938 |
121 | Platelet activation_Homo sapiens_hsa04611 | 0.32974210 |
122 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.32598094 |
123 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.28665769 |